Clopidogrel Acino Pharma GmbH European Union - English - EMA (European Medicines Agency)

clopidogrel acino pharma gmbh

acino pharma gmbh - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.for further information please refer to section 5.1.

Clopidogrel 1A Pharma European Union - English - EMA (European Medicines Agency)

clopidogrel 1a pharma

acino pharma gmbh  - clopidogrel - peripheral vascular diseases - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.patients suffering from acute coronary syndrome:- non st segment elevation acute coronary syndrome (unstable angina or non q wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa).- st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.for further information please refer to section 5.1.

Clopidogrel Acino Pharma European Union - English - EMA (European Medicines Agency)

clopidogrel acino pharma

acino pharma gmbh - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.for further information please refer to section 5.1.

Tadalafil Aristo Pharma 5mg film-coated tablets Malta - English - Medicines Authority

tadalafil aristo pharma 5mg film-coated tablets

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 5 mg - urologicals

Tadalafil Aristo Pharma 10mg film-coated tablets Malta - English - Medicines Authority

tadalafil aristo pharma 10mg film-coated tablets

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 10 mg - urologicals

Tadalafil Aristo Pharma 20mg film-coated tablets Malta - English - Medicines Authority

tadalafil aristo pharma 20mg film-coated tablets

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 20 mg - urologicals

Clarithromycin 250mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

clarithromycin 250mg tablets

hec pharm gmbh - clarithromycin - oral tablet - 250mg

Clarithromycin 500mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

clarithromycin 500mg tablets

hec pharm gmbh - clarithromycin - oral tablet - 500mg

Dutasteride/Tamsulosin Uropharm 0.5mg/0.4mg Hard Capsules Malta - English - Medicines Authority

dutasteride/tamsulosin uropharm 0.5mg/0.4mg hard capsules

abanta pharma gmbh reichsstraße 78, 58840 plettenberg , germany - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 mg tamsulosin hydrochloride 0.4 mg - urologicals

Potassium iodide G.L. Pharma 65 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

potassium iodide g.l. pharma 65 mg tablets

g.l. pharma gmbh - potassium iodide - tablet - 65 milligram(s) - antidotes; potassium iodide